Childhood anaemia is defined by the World Health Organization (WHO) using age-specific haemoglobin thresholds. These thresholds specify the haemoglobin levels below which a child is considered anaemic, varying according to different age groups.
Impact of anaemia on children includes significant effects on growth, cognitive development, and immunity, leading to potential long-term health consequences.
Morphological characteristics of red blood cells (RBC) involve assessing the shape, size, and appearance of RBCs to aid in classifying the type of anaemia.
Age-related classification of anaemia considers the child's age when diagnosing and categorizing anaemia, as haemoglobin thresholds and RBC morphology vary across different developmental stages.
Anaemia in children is diagnosed based on WHO's age-specific haemoglobin thresholds, which differ for infants, young children, and older children. Blood loss must be excluded at all ages when diagnosing anaemia, ensuring that the low haemoglobin is due to other causes such as decreased production or increased destruction of RBCs.
The classification of childhood anaemia involves evaluating the morphology of RBCs, which provides clues about the underlying cause. This assessment is tailored to the child's age, recognizing that the normal haemoglobin levels and RBC characteristics change as children grow.
Understanding childhood anaemia requires recognizing its age-specific definitions, its profound impact on development, and the importance of morphological assessment in classification, all tailored to the child's age group.
Excessive loss of RBC: The removal of red blood cells from circulation beyond normal levels, often due to external factors such as parasites or bleeding.
Deficient production by bone marrow: A condition where the bone marrow fails to produce enough red blood cells, as seen in aplastic anaemia or leukaemia.
Excessive destruction of RBC: An increased breakdown of red blood cells, which can be inherited or acquired, leading to haemolytic anaemia.
Hereditary haemolytic anaemia: A form of haemolytic anaemia caused by inherited defects that result in the premature destruction of RBCs.
Aplastic anaemia: A bone marrow failure condition characterized by the inability to produce sufficient blood cells, including RBCs.
Anaemia causes are categorized into loss, decreased production, or increased destruction of RBCs. Excessive loss of RBCs can occur due to parasites or bleeding, contributing to anaemia. Bone marrow failure conditions, such as aplastic anaemia, lead to deficient RBC production. Hereditary haemolytic anaemias involve inherited defects that cause RBC destruction, which can be distinguished from acquired causes. Excessive destruction of RBCs may also be caused by factors like haemolytic anaemia, which can be hereditary or acquired.
Classifying anaemia by its underlying pathophysiological mechanism—loss, decreased production, or destruction—guides targeted diagnosis and management strategies.
Prenatal predisposing factors: Factors affecting the fetus before birth that increase the risk of anaemia, such as low birth weight (LBW) infants and maternal nutritional deficiencies.
Postnatal factors: Conditions after birth that influence anaemia risk, including dietary deficiencies, infections, and other health issues like diarrhoea.
Nutritional deficiencies in developing countries: Common deficiencies include iron and folate, which are prevalent due to malnutrition and inadequate diets.
Parasite endemicity: The widespread presence of parasites in certain areas, contributing significantly to anaemia through blood loss and nutritional depletion.
Low birth weight (LBW) infants as risk group: Infants born with LBW are at higher risk of developing anaemia due to their vulnerability to nutritional deficiencies and infections.
Iron deficiency is the most common cause of anaemia in developing countries. Prenatal factors, such as maternal nutritional status, influence early childhood anaemia risk, while postnatal factors like dietary intake and infections further contribute. Dietary folate deficiency is prevalent in malnourished populations, often co-occurring with other nutritional deficiencies. Parasite infections are a significant contributor to anaemia in endemic areas, causing blood loss and impairing nutrient absorption. Certain groups, including low birth weight infants and children with diarrhoea, are at higher risk of developing anaemia due to their increased vulnerability to nutritional deficiencies and infections.
Epidemiology underscores the complex interplay of nutritional deficiencies, infections, and socio-demographic factors in shaping the high prevalence of childhood anaemia in developing countries.
Non-specific symptoms of anaemia include general signs such as lethargy, irritability, and pica. These symptoms are often subtle and can be mistaken for other conditions, making early detection challenging.
Systemic adaptation to anaemia refers to the body's physiological responses that initially mask the severity of anaemia. These adaptations help maintain tissue oxygenation despite reduced red blood cell count but may delay recognition of the condition.
Specific signs:
Ejection systolic murmur in anaemia is a heart sound that can be heard due to increased blood flow across the aortic valve, often associated with high cardiac output states in anaemic patients.
Recurrent infections as a manifestation of anaemia occur because impaired immunity, often due to deficiencies like iron or vitamin B12, predisposes children to repeated infections.
Initial symptoms of anaemia are often non-specific, including lethargy, irritability, and pica, which can delay diagnosis. Systemic adaptations, such as increased cardiac output and redistribution of blood flow, may initially conceal the severity of anaemia, making early detection more difficult.
Physical signs like pallor and koilonychias are key indicators of iron deficiency anaemia, providing visual clues to clinicians. Splenomegaly and the presence of an ejection systolic murmur suggest a more chronic or severe form of anaemia, reflecting underlying systemic changes and increased cardiac workload.
Recurrent infections are common in children with anaemia because the condition impairs immune function, increasing susceptibility to bacterial and parasitic infections.
Recognizing both subtle symptoms and specific physical signs is essential for early detection of anaemia in children, enabling timely intervention and management.
Complete blood count (CBC): A blood test that provides an initial assessment of anemia by measuring hemoglobin (Hb), mean corpuscular volume (MCV), and red cell distribution width (RDW). It helps identify the presence and general type of anemia.
Iron studies: A group of tests including serum iron, ferritin, and transferrin saturation. Serum iron measures circulating iron; ferritin indicates iron storage levels; transferrin saturation assesses the percentage of transferrin bound with iron. These tests confirm iron deficiency anemia.
Reticulocyte count: A measurement of young red blood cells (reticulocytes) in the blood. It helps differentiate whether anemia is due to decreased production or increased destruction of RBCs.
Peripheral blood smear: A microscopic examination of blood cells that reveals RBC morphology. It aids in classifying anemia by identifying abnormalities such as microcytosis, hypochromia, or other morphological features.
Bone marrow aspirate: A procedure to obtain marrow tissue for examination. It is definitive for diagnosing conditions like aplastic anemia by assessing marrow cellularity and erythropoiesis.
CBC provides an initial assessment of anemia, including measurements of hemoglobin, MCV, and RDW, which help determine the anemia’s general characteristics.
Low ferritin and serum iron levels confirm iron deficiency as the cause of anemia, especially in cases of iron deficiency anemia.
Reticulocyte count helps differentiate between causes of anemia by indicating whether the bone marrow is producing RBCs adequately or if destruction is predominant.
Peripheral blood smear reveals RBC morphology, aiding in the classification of anemia (e.g., microcytic, hypochromic), and can identify abnormal cell shapes or inclusions.
Bone marrow aspirate is the definitive test for diagnosing aplastic anemia, providing detailed insight into marrow cellularity and erythropoietic activity.
Laboratory tests are essential tools to differentiate anemia types and guide appropriate treatment, with each test providing specific information about RBC production, destruction, and iron status.
Iron deficiency anaemia
AUTHOR (no date): The most common cause of anaemia in early childhood, resulting from inadequate iron levels necessary for hemoglobin synthesis.
Megaloblastic anaemia
AUTHOR (no date): A form of anaemia caused by deficiency of folate or vitamin B12, leading to abnormal, enlarged red blood cell precursors in the marrow.
Anaemia of protein-energy malnutrition (PEM)
AUTHOR (no date): A type of anaemia characterized by normocytic, normochromic red blood cells, with increased iron stores in the marrow, often associated with overall nutritional deficiency.
Anaemia of chronic infection and systemic disease
AUTHOR (no date): Anemia caused by inflammatory cytokines and iron sequestration during prolonged infections or systemic illnesses, impairing iron utilization and red blood cell production.
Haemolytic anaemia
AUTHOR (no date): A condition involving increased destruction of red blood cells, often presenting with clinical jaundice and splenomegaly, which may be severe and self-limiting or chronic.
Identifying the common causes of anaemia enables focused clinical evaluation and management strategies, ensuring targeted treatment based on the underlying pathology.
Microcytosis and hypochromia: Microcytosis refers to the presence of smaller-than-normal red blood cells, while hypochromia indicates red cells with reduced hemoglobin content, leading to paler appearance. These changes often precede the development of anaemia.
Increased red cell distribution width (RDW): RDW measures the variation in red blood cell size. An increased RDW suggests a mix of normal and smaller, hypochromic cells, which is characteristic of iron deficiency anaemia.
Therapeutic trial of iron: A clinical approach where iron supplementation is given to assess whether anaemia improves, thereby confirming iron deficiency as the cause.
Oral ferrous sulphate treatment: The standard therapy for iron deficiency anaemia involves administering ferrous sulphate orally at a dose of 6 mg of elemental iron per kilogram of body weight daily.
Differential diagnosis including thalassaemia trait: Conditions such as thalassaemia trait can cause microcytosis and hypochromia, similar to iron deficiency, and must be distinguished through clinical and laboratory evaluation.
Iron deficiency anaemia shows characteristic laboratory findings, including low ferritin, serum iron, and transferrin saturation. Microcytosis and hypochromia are early indicators that appear before the full development of anaemia. The response to iron therapy, specifically oral ferrous sulphate at 6 mg elemental iron/kg/day, is a key diagnostic confirmation. Differential diagnoses such as thalassaemia trait and anaemia of chronic disease should be considered, as they can present with similar blood picture but require different management strategies.
The diagnosis and management of iron deficiency anaemia depend on specific laboratory findings and the patient's response to iron therapy, making therapeutic trial a crucial step in confirming iron deficiency as the cause.
(Absent — no explicit dates provided in the content)
| Aspect | Childhood Anaemia | Causes & Classification | Epidemiology & Risk Factors | Clinical Presentation | Laboratory Investigations |
|---|---|---|---|---|---|
| Definition | Age-specific haemoglobin thresholds per WHO | Loss, decreased production, destruction of RBCs | Prenatal (maternal nutrition, LBW), postnatal (diet, infections) | Non-specific symptoms, pallor, koilonychias, splenomegaly | CBC (Hb, MCV, RDW), iron studies (serum iron, ferritin, transferrin saturation) |
| Impact | Affects growth, cognition, immunity | Excessive loss (parasites, bleeding), marrow failure (aplastic anaemia), hemolytic (hereditary or acquired) | Iron deficiency most common in developing countries | Systemic adaptation masks severity; signs include murmurs and recurrent infections | Morphological RBC assessment aids classification |
| Age-related | Thresholds vary with age; morphology varies with age | Classification guides treatment; morphology helps identify cause | LBW infants and children with diarrhoea at higher risk | Early symptoms are subtle; physical signs are key clues | Blood tests confirm diagnosis and type |
| Author/Concept | Key Point |
|---|---|
| WHO | Defines age-specific haemoglobin thresholds for anaemia |
| Morphology of RBCs | Critical in classifying anaemia types |
| Iron studies | Essential for diagnosing iron deficiency anaemia |
Teste seu conhecimento sobre Childhood Anemia: Causes, Classification, and Management com 9 perguntas de múltipla escolha com correções detalhadas.
1. How should a healthcare provider apply the WHO's criteria to diagnose childhood anemia in a clinical setting?
2. According to WHO guidelines, how does the diagnosis of childhood anemia vary across different age groups?
Memorize os conceitos chave de Childhood Anemia: Causes, Classification, and Management com 9 flashcards interativos.
Childhood anaemia — WHO definition?
Age-specific haemoglobin thresholds vary by age.
Childhood anaemia — WHO definition?
Age-specific haemoglobin thresholds below normal.
Causes of childhood anaemia — classification?
Loss, decreased production, or increased destruction of RBCs.
Importe seu curso e a IA gera fichas, quizzes e flashcards em 30 segundos.
Gerador de fichas